MoonLake Immunotherapeutics (MLTX) Statistics & Valuation Metrics - Stocknear

MoonLake Immunotherapeuti...

NASDAQ: MLTX · Real-Time Price · USD
61.99
5.61 (9.95%)
At close: Sep 26, 2025, 3:59 PM
61.96
-0.05%
After-hours: Sep 26, 2025, 07:55 PM EDT

MoonLake Immunotherapeutics Statistics

Share Statistics

MoonLake Immunotherapeutics has 63.5M shares outstanding. The number of shares has increased by 0.93% in one year.

63.5M
0.93%
0.3%
93.45%
55.14M
3,674
0.63%

Short Selling Information

The latest short interest is 4.95M, so 7.79% of the outstanding shares have been sold short.

4.95M
7.79%
17.48%
5.97

Valuation Ratios

The PE ratio is -28.62 and the forward PE ratio is -13.96. MoonLake Immunotherapeutics's PEG ratio is -0.18.

-28.62
-13.96
0
n/a
7.62
-29.07
-0.18
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for MoonLake Immunotherapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 21.11, with a Debt / Equity ratio of 0.01.

21.11
21.11
0.01
-0.02
-0.02
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.19M
100
0
n/a

Taxes

282.2K
-0.23%

Stock Price Statistics

The stock price has increased by 25.49% in the last 52 weeks. The beta is 1.27, so MoonLake Immunotherapeutics's price volatility has been higher than the market average.

1.27
25.49%
54.63
46.43
65.43
579,352

Income Statement

n/a
-1.38M
-143.09M
-118.94M
-119.58M
-120.96M
-1.89
Full Income Statement

Balance Sheet

The company has 180.43M in cash and 2.83M in debt, giving a net cash position of 177.6M.

180.43M
2.83M
177.6M
-235.59M
460.1M
428.12M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -116.59M and capital expenditures -519.52K, giving a free cash flow of -117.11M.

-116.59M
-519.52K
-117.11M
-1.86
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for MLTX is $70, which is 12.9% higher than the current price. The consensus rating is "Buy".

$70
12.9%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

19.3
2